描述 |
PD168393是一个强的,不可逆转的EGFR抑制剂,IC50是0.7 nM. |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
靶点 |
EGFR:0.7 nM (IC50)
|
||||||||||||
溶解度 |
体外:
DMSO:≥30mg / mL(81.25 mM) * “≥”表示可溶,但饱和度未知。
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
C=CC(NC1=CC2=C(NC3=CC=CC(Br)=C3)N=CN=C2C=C1)=O |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
奥希替尼 | 酪氨酸磷酸化抑制剂AG 490 | 来那替尼 | 金雀异黄酮 | (-)-表没食子儿茶素没食子酸酯 | 4-(3-氯苯胺)-6,7-二甲氧基喹唑啉盐酸盐 | 达克替尼 | 图卡蒂尼(伊尔比尼替尼,ONT-380) | 波齐奥替尼(HM781-36B) | N-[3-[[2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]噻吩并[3,2-d]嘧啶-4-基]氧基]苯基]-2-丙烯酰胺 | AZD 8931 | AZD-3759 | 吡咯替尼 | 卡纽替尼二盐酸盐 | (3R,4R)-4-氨基-1-[[4-[(3-甲氧基苯基)氨基]吡咯并[2,1-f][1,2,4]三嗪-5-基]甲基]哌啶-3-醇 |
密度 | 1.6±0.1 g/cm3 |
---|---|
沸点 | 571.1±50.0 °C at 760 mmHg |
熔点 | 279℃ |
分子式 | C17H13BrN4O |
分子量 | 369.215 |
闪点 | 299.2±30.1 °C |
精确质量 | 368.027252 |
PSA | 70.40000 |
LogP | 3.72 |
蒸汽压 | 0.0±1.6 mmHg at 25°C |
折射率 | 1.744 |
储存条件 | -20°C |
危险品运输编码 | NONH for all modes of transport |
---|
~43%
N-[4-[(3-溴苯基)氨基...
194423-15-9
|
|
文献:Warner-Lambert Company Patent: US6344459 B1, 2002 ; Location in patent: Page column 48 ; US 6344459 B1 |
|
~84%
|
文献:Wyeth Patent: EP1100788 B1, 2005 ; Location in patent: Page/Page column 7 ;
|
~56%
|
文献:Wyeth Patent: EP1100788 B1, 2005 ; Location in patent: Page/Page column 9-10 ;
|
~49%
|
文献:Wyeth Patent: EP1100788 B1, 2005 ; Location in patent: Page/Page column 8 ;
|
~11%
|
文献:Pawar, Vijaykumar G.; Sos, Martin L.; Rode, Haridas B.; Rabiller, Matthias; Heynck, Stefanie; Van Otterlo, Willem A. L.; Thomas, Roman K.; Rauh, Daniel Journal of Medicinal Chemistry, 2010 , vol. 53, # 7 p. 2892 - 2901
|
~%
|
文献:American Cyanamid Company Patent: EP787722 A1, 1997 ; Title/Abstract Full Text Show Details Wyeth Holdings Corporation Patent: EP980244 B1, 2003 ;
|
~%
|
文献:Tsou; Mamuya; Johnson; Reich; Gruber; Ye; Nilakantan; Shen; Discafani; DeBlanc; Davis; Koehn; Greenberger; Wang; Wissner Journal of Medicinal Chemistry, 2001 , vol. 44, # 17 p. 2719 - 2734
|
~%
|
文献:Tsou; Mamuya; Johnson; Reich; Gruber; Ye; Nilakantan; Shen; Discafani; DeBlanc; Davis; Koehn; Greenberger; Wang; Wissner Journal of Medicinal Chemistry, 2001 , vol. 44, # 17 p. 2719 - 2734
|
N-[4-[(3-溴苯基)氨基]-6-喹唑啉]-2-丙酰胺上游产品? 5 | |
---|---|
|
|
|
|
N-[4-[(3-溴苯基)氨基]-6-喹唑啉]-2-丙酰胺下游产品? 0 |
2-Propenamide (N-[4-[(3-bromophenyl)amino]-6-quinazolinyl] |
nchembio866-comp2 |
pd 168393 |
2-Propenamide, N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]- |
N-{4-[(3-Bromophenyl)amino]-6-quinazolinyl}acrylamide |
PD168393 |